Skip to main content Accesibility Help
×
×
Home

A Cost-Effectiveness-Assessing Model of Vaccination for Varicella and Zoster

  • M. Comba (a1), S. Martorano-Raimundo (a2) and E. Venturino (a1)
Abstract

A decision analytical model is presented and analysed to assess the effectiveness and cost-effectiveness of routine vaccination against varicella and herpes-zoster, or shingles. These diseases have as common aetiological agent the varicella-zoster virus (VZV). Zoster can more likely occur in aged people with declining cell-mediated immunity. The general concern is that universal varicella vaccination might lead to more cases of zoster: with more vaccinated children exposure of the general population to varicella infectives become smaller and thus a larger proportion of older people will have weaker immunity to VZV, leading to more cases of reactivation of zoster. Our compartment model shows that only two possible equilibria exist, one without varicella and the other one where varicella and zoster both thrive. Threshold quantities to distinguish these cases are derived. Cost estimates on a possible herd vaccination program are discussed indicating a possible tradeoff choice.

Copyright
Corresponding author
Corresponding author. E-mail: ezio.venturino@unito.it
References
Hide All
[1] Arvin, A. M., Gershon, A. A.. Live attenuated varicella vaccine. Ann. Rev. Microbiol., 50 (1996), 59100.
[2] Arvin, A. M., Gershon, A. A.. Live attenuated varicella vaccine. Ann Rev Microbiol., 50 (1996), 59100.
[3] Brisson, M., Edmunds, W. J., Gay, N. J., Law, B., De Serres, G.. Modelling the Impact of Immunization on the Epidemiology of Varicella Zoster Virus. Epidemiology and Infection, 125 (2000), 651669.
[4] CDC. Prevention of varicella : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56 (2007), No. RR4, OpenURL.
[5] Centers for Disease Control and Prevention. Prevention of varicella : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 45 (1997), No. RR-11, 35–40.
[6] Deguen, S., Flahault, A.. Impact on Immunization of Seasonal Cycle of Chickenpox. European Journal of Epidemiology, 16 (2000), 11771181.
[7] Diekmann, O., Heesterbeek, J. A. P., Metz, J. A. J.. On the definition and the computation of the basic reproduction ratio in models for infectious diseases in heterogeneous populations. Journal of Mathematical Biology, 28 (1990), No. 4, 365382, Doi : 10.1007/BF00178324.
[8] Edmunds, W. J., Brisson, M.. The effect of vaccination on the epidemiology of varicella zoster virus. Journal of Infection, 44 (2002), 211219.
[9] Forde, J. E., Meeker, B.. A model of varicella-zoster reactivation. Mathematical Biosciences and Engineering, 7 (2010), 765777.
[10] Garnett, G. P., Ferguson, N. M.. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev. Med. Virol., 6 (1996), 151161.
[11] Garnett, G. P., Grenfell, B. T.. The Epidemiology of Varicella-Zoster Virus Infections : The Influence of Varicella on the Prevalence of Herpes Zoster. Epidemiology and Infection, 108 (1992), 513528.
[12] Hambleton, S., Steinberg, S. P., La Russa, P. S., Shapiro, E. D., Gershon, A. A.. Risk of Herpes Zoster in adults immunized with varicella vaccine. J. Infect. Dis., 197 (2008), S196199.
[13] Hope-Simpson, R. E.. The nature of herpes zoster : a long term study and a new hypothesis. Proc. Roy. Soc. Med., 58 (1965), 920.
[14] Hornberger, J., Robertus, K.. Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. Ann Intern Med., 145 (2006), 317325.
[15] Karhunen, M., Leino, T., Salo, H., Davidkin, I., Kilpi, T., Auranen, K.. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect., 138 (2010), No. 4, 469481.
[16] Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Hongyuan Zhang, J., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., Kauffman, C. A., Pachucki, C. T., Neuzil, K. M., Betts, R. F., Wright, P. F., Griffin, M. R., Brunell, P., Soto, N. E., Marques, A. R., Keay, S. K., Goodman, R. P., Cotton, D. J., Gnann, J. W. Jr., Loutit, J., Holodniy, M., Keitel, W. A., Crawford, G. E., Yeh, S.-S., Lobo, Z., Toney, J. F., Greenberg, R. N., Keller, P. M., Harbecke, R., Hayward, A. R., Irwin, M. R., Kyriakides, T. C., Chan, C. Y., Chan, I. S. F., Wang, W. W. B., Annunziato, P. W., Silber, J. L.. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med., 352 (2005), No. 22, 22712284.
[17] Oxman, M. N., Levin, M.J.. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis., 197 (2008), Suppl. 2, S2285236.
[18] Socan, M., Berginc, N., Lajovic, J.. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health, 10 :360 (2010), 16.
[19] Schuette, M. C., Hethcote, H. W.. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol., 61 (1999), No. 6, 10311064.
[20] G. Soldato. Nuove strategie preventive vaccinali : vantaggi e limiti del vaccino antivaricella (New preventive vaccine strategies : advantages and limits of the vaccine against chickenpox). Thesis (Advisor Prof. C. Granchelli), University “G. D’Annunzio” of Chieti-Pescara, Italy, 2005.
[21] Thiry, N., Beutels, P., Tancredi, F., Romanò, L., Zanetti, A., Bonanni, P., Gabutti, G., Van Damme, P.. An economic evaluation of varicella vaccination in italian adolescents. Vaccine 22, (2004), 27-28, 35463562.
[22] van Hoek, A. J., Gay, N., Opstelten, W., Edmunds, W. J.. Estimating the cost-effectiveness of vaccination against Herpes Zoster in England and Wales. Vaccine, 27 (2009), No. 9, 14541467.
[23] Van Hoek, A. J., Melegaro, A., Zaghenid, E. W., Edmunds, J., Gay, N.. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine, 29 (2011), 24112420.
[24] Wharton, M.. The epidemiology of varicella-zoster virus infections. Infect Dis Clinics N Am, 10 (1996), 571581.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Mathematical Modelling of Natural Phenomena
  • ISSN: 0973-5348
  • EISSN: 1760-6101
  • URL: /core/journals/mathematical-modelling-of-natural-phenomena
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed